Search
for
Sort by
Research 30 of 1000+
- Non-surgical management of BPH: An updated review of current literature and state of the art on natural compounds and medical therapy
- The influence of secoisolariciresinol diglusoside on non-emasculated rat in BPH
- Selective non-steroidal inhibitors of 5α-reductase type 1
- 410 NON-INVASIVE DIAGNOSIS OF PROSTATE CANCER FROM BODY FLUIDS USING A PANEL OF TUMOR SUPPRESSOR GENES
- Synthesis of phenanthridin-3-one derivatives: Non-steroidal inhibitors of steroid 5-α-reductase
- Association between prostate‐specific antigen and serum testosterone: A systematic review and meta‐analysis
- Novel tip-loaded dissolving and implantable microneedle array patches for sustained release of finasteride
- Health Risks Associated with Long-Term Finasteride and Dutasteride Use: It’s Time to Sound the Alarm
- Co-administration of 5α-reductase Inhibitors Worsens the Adverse Metabolic Effects of Prescribed Glucocorticoids
- Non-Steroidal Modulation of the 5-Alpha Reductase Axis: A Dual Therapeutic Strategy for Prostatic Chemoprevention and Androgenetic Alopecia
- Association of Frailty Index with Clinical BPH Progression and Serious Adverse Events: the MTOPS Trial
- Current treatment of BPH
- Faculty Opinions recommendation of Androgenetic alopecia as an early marker of benign prostatic hyperplasia.
- Editorial: Advances in reproductive biotechnologies in carnivores
- MP09-17 METHYLATION OF SRD5A2 IN THE BLOOD AS A NOVEL BIOMARKER TO PREDICT SENSITIVITY TO 5-ARI TREATMENT
- Topical Application of Thermobalancing Therapy Enabled by Therapeutic Device Treats Enlarged Prostate and Improves Men's Quality of Life; New Opportunity in BPH Treatment
- Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- HPLC characterization, molecular docking, QSAR and molecular dynamics simulation of Alstonia boonei phytochemical analogs as potent 5-alpha reductase inhibitors
- Polygenic risk score predicting susceptibility and outcome of benign prostatic hyperplasia in the Han Chinese
- Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial
- Generation of comparative pharmacophoric model for steroidal 5α-reductase I and II inhibitors: A 3D-QSAR study on 6-azasteroids
- Androgenic Alopecia Is Associated With More Severe Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
- Endocrine treatment of benign prostatichypertrophy: Current concepts
- Adverse effects of 5α-reductase inhibitors: What do we know, don’t know, and need to know?
- Comparison of clinical trials with finasteride and dutasteride.
- Steroid 5α-reductase inhibition by polymethoxyflavones
- Clinical effects and economical impact of dutasteride and finasteride therapy in Italian men with LUTS
- The urologic impact of long-term finasteride 1-mg use for androgenic alopecia: a matched-cohort database analysis
- Influence of tamsulosin and finasteride on circadian rhythm and cardiac function in male elderly patients with chronic heart failure